Literature DB >> 8586091

Uptake of technetium-99m hexamethylpropylene amine oxime labelled white cells in lymph nodes involved in non-Hodgkin's lymphoma.

A M AL-Nahhas1, P Hjiyiannakis, P A Hammersley, V R McCready, A H Horwich.   

Abstract

Radiolabelled white cell scanning is widely used to detect the presence of infection. We present a case of non-Hodgkin s lymphoma manifesting with signs and symptoms suggestive of infection, in which a technetium-99m hexamethylpropylene amine oxime (99mTc-HMPAO) white cell scan demonstrated high uptake in lymph nodes involved by lymphoma. Differential cell analysis showed preferential lymphocyte labelling. The classification and management of the disease were changed accordingly. Our findings suggest that a future role for 99mTc-HMPAO labelled white cells in the assessment of disease activity of lymphoma should be investigated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8586091     DOI: 10.1007/bf01791154

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  8 in total

1.  Evaluation of 111In leukocyte whole body scanning.

Authors:  I R McDougall; J E Baumert; R L Lantieri
Journal:  AJR Am J Roentgenol       Date:  1979-11       Impact factor: 3.959

2.  Gallium-67 citrate imaging in Hodgkin's disease: final report of cooperative group.

Authors:  G S Johnston; M F Go; R S Benua; S M Larson; G A Andrews; K F Hubner
Journal:  J Nucl Med       Date:  1977-07       Impact factor: 10.057

3.  Ga-67 citrate imaging in malignant lymphoma: final report of cooperative group.

Authors:  G A Andrews; K F Hubner; R H Greenlaw
Journal:  J Nucl Med       Date:  1978-09       Impact factor: 10.057

4.  Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors.

Authors:  H Minn; H Joensuu; A Ahonen; P Klemi
Journal:  Cancer       Date:  1988-05-01       Impact factor: 6.860

5.  Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study.

Authors:  S Leskinen-Kallio; U Ruotsalainen; K Någren; M Teräs; H Joensuu
Journal:  J Nucl Med       Date:  1991-06       Impact factor: 10.057

Review 6.  The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas.

Authors:  E S Jaffe; A Zarate-Osorno; D W Kingma; M Raffeld; L J Medeiros
Journal:  Ann Oncol       Date:  1994       Impact factor: 32.976

7.  Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma.

Authors:  R Paul
Journal:  J Nucl Med       Date:  1987-03       Impact factor: 10.057

8.  Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity.

Authors:  J Okada; K Yoshikawa; M Itami; K Imaseki; K Uno; J Itami; J Kuyama; A Mikata; N Arimizu
Journal:  J Nucl Med       Date:  1992-03       Impact factor: 10.057

  8 in total
  2 in total

1.  Does leukocyte scintigraphy answer the need for a more widely available radiopharmaceutical that can detect and assess the proliferative state of lymphoma?

Authors:  C Van de Wiele; M Simons; L Noens; R A Dierckx
Journal:  Eur J Nucl Med       Date:  1996-04

2.  Nuclear medicine imaging of infection in cancer patients (with emphasis on FDG-PET).

Authors:  Chantal P Bleeker-Rovers; Fidel J Vos; Winette T A van der Graaf; Wim J G Oyen
Journal:  Oncologist       Date:  2011-06-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.